Eris Lifesciences Limited (BOM:540596)
India flag India · Delayed Price · Currency is INR
1,176.20
-21.30 (-1.78%)
At close: Oct 28, 2026

Eris Lifesciences Statistics

Total Valuation

BOM:540596 has a market cap or net worth of INR 163.07 billion. The enterprise value is 184.80 billion.

Market Cap163.07B
Enterprise Value 184.80B

Important Dates

The last earnings date was Monday, October 26, 2026.

Earnings Date Oct 26, 2026
Ex-Dividend Date May 29, 2026

Share Statistics

Current Share Class 138.74M
Shares Outstanding n/a
Shares Change (YoY) +1.26%
Shares Change (QoQ) -0.04%
Owned by Insiders (%) 59.40%
Owned by Institutions (%) 24.40%
Float 44.36M

Valuation Ratios

The trailing PE ratio is 22.94 and the forward PE ratio is 23.71.

PE Ratio 22.94
Forward PE 23.71
PS Ratio 4.92
PB Ratio 3.94
P/TBV Ratio n/a
P/FCF Ratio 30.45
P/OCF Ratio 17.42
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.15, with an EV/FCF ratio of 34.51.

EV / Earnings 26.12
EV / Sales 5.57
EV / EBITDA 16.15
EV / EBIT 21.17
EV / FCF 34.51

Financial Position

The company has a current ratio of 0.67, with a Debt / Equity ratio of 0.59.

Current Ratio 0.67
Quick Ratio 0.33
Debt / Equity 0.59
Debt / EBITDA 2.12
Debt / FCF 4.54
Interest Coverage 4.67

Financial Efficiency

Return on equity (ROE) is 18.79% and return on invested capital (ROIC) is 14.00%.

Return on Equity (ROE) 18.79%
Return on Assets (ROA) 7.42%
Return on Invested Capital (ROIC) 14.00%
Return on Capital Employed (ROCE) 17.87%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee 12.02M
Profits Per Employee 2.57M
Employee Count2,758
Asset Turnover 0.45
Inventory Turnover 2.03

Taxes

Income Tax -782.30M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -27.92% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -27.92%
50-Day Moving Average 1,249.94
200-Day Moving Average 1,354.89
Relative Strength Index (RSI) 47.72
Average Volume (20 Days) 41,712

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, BOM:540596 had revenue of INR 33.15 billion and earned 7.08 billion in profits. Earnings per share was 51.28.

Revenue33.15B
Gross Profit 24.17B
Operating Income 8.75B
Pretax Income 6.40B
Net Income 7.08B
EBITDA 11.47B
EBIT 8.75B
Earnings Per Share (EPS) 51.28
Full Income Statement

Balance Sheet

The company has 2.54 billion in cash and 24.30 billion in debt, with a net cash position of -21.75 billion.

Cash & Cash Equivalents 2.54B
Total Debt 24.30B
Net Cash -21.75B
Net Cash Per Share n/a
Equity (Book Value) 41.42B
Book Value Per Share 298.96
Working Capital -8.80B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 9.36 billion and capital expenditures -4.01 billion, giving a free cash flow of 5.36 billion.

Operating Cash Flow 9.36B
Capital Expenditures -4.01B
Depreciation & Amortization 2.71B
Net Borrowing 346.80M
Free Cash Flow 5.36B
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 72.90%, with operating and profit margins of 26.41% and 21.34%.

Gross Margin 72.90%
Operating Margin 26.41%
Pretax Margin 19.31%
Profit Margin 21.34%
EBITDA Margin 34.59%
EBIT Margin 26.41%
FCF Margin 16.16%

Dividends & Yields

This stock pays an annual dividend of 7.21, which amounts to a dividend yield of 0.61%.

Dividend Per Share 7.21
Dividend Yield 0.61%
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio 14.12%
FCF Payout Ratio n/a
Buyback Yield -1.26%
Shareholder Yield -0.65%
Earnings Yield 4.36%
FCF Yield 3.28%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Analyst Forecast

The average price target for BOM:540596 is 1,514.40, which is 28.75% higher than the current price. The consensus rating is "Strong Buy".

Price Target 1,514.40
Price Target Difference 28.75%
Analyst Consensus Strong Buy
Analyst Count 10
Revenue Growth Forecast (3Y) 12.86%
EPS Growth Forecast (3Y) 13.44%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 6